Mercer Global Advisors
ABMD

Mercer Global Advisors’s Abiomed Inc ABMD Stock Holding History

Mercer Global Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,962
Closed -$482K – 2014
2022
Q3 		$482K Buy
1,962
+56
+3% +$15.1K ﹤0.01% 1156
2022
Q2 		$472K Buy
1,906
+603
+46% +$163K ﹤0.01% 1173
2022
Q1 		$432K Buy
1,303
+5
+0.4% +$1.54K ﹤0.01% 1301
2021
Q4 		$466K Buy
1,298
+42
+3% +$14.2K ﹤0.01% 1248
2021
Q3 		$409K Sell
1,256
-41
-3% -$13.9K ﹤0.01% 1280
2021
Q2 		$405K Buy
1,297
+70
+6% +$21.5K ﹤0.01% 1244
2021
Q1 		$391K Buy
1,227
+356
+41% +$114K ﹤0.01% 1194
2020
Q4 		$282K Buy
871
+50
+6% +$13.8K ﹤0.01% 1087
2020
Q3 		$227K Buy
+821
New +$237K ﹤0.01% 1069
2019
Q2 		– Sell
-870
Closed -$248K – 1200
2019
Q1 		$248K Buy
+870
New +$289K 0.01% 904

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mercer Global Advisors's ABMD Position: Q4 2022 in Review

Mercer Global Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,962 shares — an estimated $482K sold.

Mercer Global Advisors first reported a position in ABMD in Q1 2019 and held it in 10 quarters. The position peaked at $482K in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Mercer Global Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Mercer Global Advisors sold 1,962 Abiomed Inc shares in Q4 2022, an estimated $482K.
  • Mercer Global Advisors first reported a position in Abiomed Inc in Q1 2019 and held it in 10 quarters.
  • Mercer Global Advisors's Abiomed Inc position peaked at $482K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Mercer Global Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.